COSCIENS Biopharma Inc. Proceeds From Exercise Of Warrants
COSCIENS Biopharma Inc. (CSCIF) reported Proceeds From Exercise Of Warrants of $20.09 million for the 12-month period ending 2021-12-31, per its 20-F/A filed 2024-07-17.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2024-07-17
| Period end | Proceeds From Exercise Of Warrants 12 month |
|---|---|
| 2021-12-31 | $20.09M 20-F/A · filed 2024-07-17 |